Cargando…
Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age?
Aging of the population is a pressing challenge for healthcare systems and knowledge of a patient’s prognosis is a key to shaping effective interventions. As the prevalence of multimorbidity strongly increases with age, the prognostic value of multiple disease diagnoses for survival among older peop...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473562/ https://www.ncbi.nlm.nih.gov/pubmed/34588816 http://dx.doi.org/10.2147/CLEP.S325348 |
_version_ | 1784575016150499328 |
---|---|
author | Thygesen, Lau Caspar Christensen, Kaare Rørth, Mikael Sørensen, Henrik Toft Vandenbroucke, Jan P Westendorp, Rudi G J |
author_facet | Thygesen, Lau Caspar Christensen, Kaare Rørth, Mikael Sørensen, Henrik Toft Vandenbroucke, Jan P Westendorp, Rudi G J |
author_sort | Thygesen, Lau Caspar |
collection | PubMed |
description | Aging of the population is a pressing challenge for healthcare systems and knowledge of a patient’s prognosis is a key to shaping effective interventions. As the prevalence of multimorbidity strongly increases with age, the prognostic value of multiple disease diagnoses for survival among older people may diminish, whereas other measures of health, such as functional status (defined as a measure of an individual’s ability to perform activities of daily living), may become more important. In this commentary, the impact of age on the prognostic value of multimorbidity is discussed, with the aim of identifying relevant alternative risk indicators for different age groups. The key question is to determine at what age the prognostic value of multimorbidity for meaningful clinical outcomes decreases and is overridden by the prognostic value of functional status. This tipping point likely depends on age, calendar time, and birth cohort. The public health and clinical implications of these tipping points are important. Among younger and middle-aged persons, interventions could be directed towards prevention and treatment of specific diseases, while among older persons efforts should focus more on improving functional levels that include physical, emotional, and social dimensions. |
format | Online Article Text |
id | pubmed-8473562 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84735622021-09-28 Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? Thygesen, Lau Caspar Christensen, Kaare Rørth, Mikael Sørensen, Henrik Toft Vandenbroucke, Jan P Westendorp, Rudi G J Clin Epidemiol Commentary Aging of the population is a pressing challenge for healthcare systems and knowledge of a patient’s prognosis is a key to shaping effective interventions. As the prevalence of multimorbidity strongly increases with age, the prognostic value of multiple disease diagnoses for survival among older people may diminish, whereas other measures of health, such as functional status (defined as a measure of an individual’s ability to perform activities of daily living), may become more important. In this commentary, the impact of age on the prognostic value of multimorbidity is discussed, with the aim of identifying relevant alternative risk indicators for different age groups. The key question is to determine at what age the prognostic value of multimorbidity for meaningful clinical outcomes decreases and is overridden by the prognostic value of functional status. This tipping point likely depends on age, calendar time, and birth cohort. The public health and clinical implications of these tipping points are important. Among younger and middle-aged persons, interventions could be directed towards prevention and treatment of specific diseases, while among older persons efforts should focus more on improving functional levels that include physical, emotional, and social dimensions. Dove 2021-09-21 /pmc/articles/PMC8473562/ /pubmed/34588816 http://dx.doi.org/10.2147/CLEP.S325348 Text en © 2021 Thygesen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Commentary Thygesen, Lau Caspar Christensen, Kaare Rørth, Mikael Sørensen, Henrik Toft Vandenbroucke, Jan P Westendorp, Rudi G J Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title | Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title_full | Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title_fullStr | Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title_full_unstemmed | Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title_short | Tipping Points – Do the Prognostic Values of Multimorbidity and Functional Status Vary with Age? |
title_sort | tipping points – do the prognostic values of multimorbidity and functional status vary with age? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473562/ https://www.ncbi.nlm.nih.gov/pubmed/34588816 http://dx.doi.org/10.2147/CLEP.S325348 |
work_keys_str_mv | AT thygesenlaucaspar tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage AT christensenkaare tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage AT rørthmikael tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage AT sørensenhenriktoft tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage AT vandenbrouckejanp tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage AT westendorprudigj tippingpointsdotheprognosticvaluesofmultimorbidityandfunctionalstatusvarywithage |